GeneDx Holdings (WGSWW) Return on Capital Employed (2021 - 2026)
GeneDx Holdings (WGSWW) reported Return on Capital Employed of 15.44% for Q1 2026, down 1156.0% year-over-year from 1.46% in Q1 2025, and down 372.24% quarter-over-quarter from 3.27% in Q4 2025.
GeneDx Holdings (WGSWW) Return on Capital Employed (2021 - 2026) Analysis & Trends
GeneDx Holdings (WGSWW) has 6 years of Return on Capital Employed data on file, last reported at 15.44% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 15.44%, down 1156.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 15.44% (down 1156.0% YoY), and the FY2025 annual result was 3.61%, up 277.0% from the prior year.
- Return on Capital Employed eased to 15.44% in Q1 2026 per WGSWW's latest filing, from 3.27% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 2.55% in Q3 2025 and troughed at 160.04% in Q1 2023.
- A 5-year average of 54.64% and a median of 37.62% in 2024 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2022 and 2023: Return on Capital Employed soared 25153 bps in 2022, then sank 8220 bps in 2023.
- A 5-year view of Return on Capital Employed shows it stood at 129.47% in 2022, then surged by 61 bps to 50.28% in 2023, then jumped by 87 bps to 6.46% in 2024, then jumped by 49 bps to 3.27% in 2025, then tumbled by 372 bps to 15.44% in 2026.
- Business Quant data shows WGSWW's Return on Capital Employed at 15.44% in Q1 2026, 3.27% in Q4 2025, and 2.55% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 4.82% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 8.12% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 6.26% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 67.98% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 14.57% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -3.63% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 10.24% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 16.90% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 45.73% |
| 10 | GeneDx Holdings | - | - | 68.21 Mn | -15.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.44% |
| Dec 31, 2025 | -3.27% |
| Sep 30, 2025 | 2.55% |
| Jun 30, 2025 | 1.42% |
| Mar 31, 2025 | -3.88% |
| Dec 31, 2024 | -6.46% |
| Sep 30, 2024 | -17.93% |
| Jun 30, 2024 | -28.70% |
| Mar 31, 2024 | -37.62% |
| Dec 31, 2023 | -50.28% |
| Sep 30, 2023 | -126.78% |
| Jun 30, 2023 | -123.73% |
| Mar 31, 2023 | -160.04% |
| Dec 31, 2022 | -129.47% |
| Sep 30, 2022 | -63.79% |
| Jun 30, 2022 | -87.55% |
| Mar 31, 2022 | -77.84% |
| Dec 31, 2021 | -93.45% |
| Sep 30, 2021 | -143.29% |
| Jun 30, 2021 | -339.07% |